2 completed, 1 terminated. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow InterMune: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients Interferon Gamma-1b, Rituximab - Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | Terminated | InterMune | 24 | 2003-03-01 | 2007-11-01 |
| Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis interferon gamma-1b - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | InterMune | 51 | 2002-04-01 | 2007-11-01 |
| Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis interferon gamma-1b - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | InterMune | 66 | 2001-02-01 | 2007-11-01 |
Cystic Fibrosis (2) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
interferon gamma-1b (3) · Rituximab (1)
United States (2)
Steve Porter, MD (1) · Steven Porter, MD (1) · Williamson Bradford, MD (1)